Cargando…
WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease
Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) emerge as promising agents to treat anemia in chronic kidney disease (CKD) but the major concern is their correlated risk of cancer development and progression. The Wilms’ tumor gene, WT1, is transcriptionally regulated by HIF and is...
Autores principales: | Lee, Wen-Chin, Chiu, Chien-Hua, Chu, Tian-Huei, Chien, Yu-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019781/ https://www.ncbi.nlm.nih.gov/pubmed/35465313 http://dx.doi.org/10.3389/fcell.2022.876723 |
Ejemplares similares
-
Editorial: WT1 in Development and Disease
por: Chau, You-Ying, et al.
Publicado: (2022) -
WT1 in Adipose Tissue: From Development to Adult Physiology
por: Kirschner, Karin M., et al.
Publicado: (2022) -
Deletion of the Wilms’ Tumor Suppressor Gene in the Cardiac Troponin-T Lineage Reveals Novel Functions of WT1 in Heart Development
por: Díaz del Moral, Sandra, et al.
Publicado: (2021) -
The Wilms Tumor Gene wt1a Contributes to Blood-Cerebrospinal Fluid Barrier Function in Zebrafish
por: Hopfenmüller, Vera L., et al.
Publicado: (2022) -
Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
por: Fang, Can-Bin, et al.
Publicado: (2020)